Evolent Health Inc.
EVH | NYSE
$4.30
+$0.05 (+1.18%)
At close: Oct 30, 2026, 4:00 PM ET
$4.30
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:01 PM ET
+1.18%
(1D)No price chart data available for 1D timeframe.
Rating
33
+0.5 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #714/1028 (Top 69%)
Key Statistics
Market Data
Market Cap $483.67M
1D Range
4.09 4.31
52W Range
2.17 6.72
Valuation (TTM)
PE -0.96
PB 1.26
EV/EBITDA -4.22
Valuation (NTM)
Forward PE 10.49
Forward PEG -0.01
Price Target $7.00
Cash Flow
FCF Yield 3.5%
SBC Adj. FCF Yield -4.4%
SBC Impact -225.0%
Margins
Gross Margin 12.9%
Operating Margin -1.4%
FCF Margin 0.8%
Growth (CAGR)
Revenue 3Y | 5Y 8.7% |
17.2%
Dil EPS 3Y | 5Y -75.6% |
-58.9%
FCF 3Y | 5Y -191.9% |
-34.8%
Returns
ROA -25.6%
ROE -99.2%
ROIC -1.9%
Financial Health
Net Debt
$850.76M
Current Ratio 1.24
Interest Coverage -0.41
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across ...
Sector Healthcare
Employees 4,200
IPO Date Jun 5, 2015
Website www.evolent.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
12
Consensus
Buy
Price Target
$7.00
Upside
+62.79%
Buy (9)
Hold (3)
Sell (0)
Add to Watchlist
Select watchlists to add or remove EVH